B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression

F. E. Bertrand; J. D. Spengeman; N. Shah; Tucker W LeBien

doi:10.1038/sj.leu.2403178

B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression

F. E. Bertrand, J. D. Spengeman, N. Shah, Tucker W LeBien

Administration (AHS)

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Infant acute lymphoblastic leukemia (ALL) is frequently characterized by the t(4;11)(q21;q23) cytogenetic abnormality encoding the MLL/AF4 oncogene, increased HOX gene expression and a pro-B/monocytoid phenotype. We have previously established a novel MLL/AF4-positive cell line, B-lineage 3 (BLIN-3), which retains several features of normal B-lineage development (functional Ig gene rearrangement and apoptotic sensitivity to stromal cell withdrawal) not generally observed in Infant ALL. We now use microarray analysis to identify patterns of gene expression in BLIN-3 that may modulate MLL/AF4 oncogenesis and contribute to the retention of normal B-lineage developmental characteristics. Comparison of 6815 expressed genes in BLIN-3 with published microarray data on leukemic blasts from t(4;11) patients indicated that BLIN-3 was unique in lacking the expression of certain HOX-A cluster genes. These results were validated by RT-PCR showing no expression of HOX A7 or HOX A9 in BLIN-3. A HOX C8 promoter reporter was active in BLIN-3, indicating that lack of HOX gene expression in BLIN-3 was not due to a nonfunctional MLL/AF4. Our results suggest that B-lineage development can proceed in t(4;11) leukemic blasts in the absence of HOX-A gene expression.

Original language	English (US)
Pages (from-to)	2454-2459
Number of pages	6
Journal	Leukemia
Volume	17
Issue number	12
DOIs	https://doi.org/10.1038/sj.leu.2403178
State	Published - Dec 2003

Bibliographical note

Funding Information:
We thank John Kersey, Paula Croonquist, Michael Linden, Brian Van Ness, Kevin Roberg-Perez (University of Minnesota Cancer Center) and Paul Doran (Affymetrix) for helpful discussions. We also thank Jay Hess (University of Pennsylvania) for kindly providing the Hox C8-Luc vector. This work was supported by National Institutes of Health Grant RO1 CA31685 (TWL) and the Leukemia Research Fund (TWL), University of Minnesota. FEB was supported by the Chris P Tkalcevic Foundation for Leukemia Research as a Special Fellow of the Leukemia and Lymphoma Society. TWL holds the Apogee Enterprises Chair in Cancer Research.

Keywords

11)
AF4
B-cell development
HOX
Leukemia
MLL
Microarray
T(4

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1038/sj.leu.2403178

OpenUrl availability

Full text

Cite this

@article{ca33d99a77c845e289e409ada1b944b1,

title = "B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression",

abstract = "Infant acute lymphoblastic leukemia (ALL) is frequently characterized by the t(4;11)(q21;q23) cytogenetic abnormality encoding the MLL/AF4 oncogene, increased HOX gene expression and a pro-B/monocytoid phenotype. We have previously established a novel MLL/AF4-positive cell line, B-lineage 3 (BLIN-3), which retains several features of normal B-lineage development (functional Ig gene rearrangement and apoptotic sensitivity to stromal cell withdrawal) not generally observed in Infant ALL. We now use microarray analysis to identify patterns of gene expression in BLIN-3 that may modulate MLL/AF4 oncogenesis and contribute to the retention of normal B-lineage developmental characteristics. Comparison of 6815 expressed genes in BLIN-3 with published microarray data on leukemic blasts from t(4;11) patients indicated that BLIN-3 was unique in lacking the expression of certain HOX-A cluster genes. These results were validated by RT-PCR showing no expression of HOX A7 or HOX A9 in BLIN-3. A HOX C8 promoter reporter was active in BLIN-3, indicating that lack of HOX gene expression in BLIN-3 was not due to a nonfunctional MLL/AF4. Our results suggest that B-lineage development can proceed in t(4;11) leukemic blasts in the absence of HOX-A gene expression.",

keywords = "11), AF4, B-cell development, HOX, Leukemia, MLL, Microarray, T(4",

author = "Bertrand, {F. E.} and Spengeman, {J. D.} and N. Shah and LeBien, {Tucker W}",

note = "Funding Information: We thank John Kersey, Paula Croonquist, Michael Linden, Brian Van Ness, Kevin Roberg-Perez (University of Minnesota Cancer Center) and Paul Doran (Affymetrix) for helpful discussions. We also thank Jay Hess (University of Pennsylvania) for kindly providing the Hox C8-Luc vector. This work was supported by National Institutes of Health Grant RO1 CA31685 (TWL) and the Leukemia Research Fund (TWL), University of Minnesota. FEB was supported by the Chris P Tkalcevic Foundation for Leukemia Research as a Special Fellow of the Leukemia and Lymphoma Society. TWL holds the Apogee Enterprises Chair in Cancer Research.",

year = "2003",

month = dec,

doi = "10.1038/sj.leu.2403178",

language = "English (US)",

volume = "17",

pages = "2454--2459",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression

AU - Bertrand, F. E.

AU - Spengeman, J. D.

AU - Shah, N.

AU - LeBien, Tucker W

N1 - Funding Information: We thank John Kersey, Paula Croonquist, Michael Linden, Brian Van Ness, Kevin Roberg-Perez (University of Minnesota Cancer Center) and Paul Doran (Affymetrix) for helpful discussions. We also thank Jay Hess (University of Pennsylvania) for kindly providing the Hox C8-Luc vector. This work was supported by National Institutes of Health Grant RO1 CA31685 (TWL) and the Leukemia Research Fund (TWL), University of Minnesota. FEB was supported by the Chris P Tkalcevic Foundation for Leukemia Research as a Special Fellow of the Leukemia and Lymphoma Society. TWL holds the Apogee Enterprises Chair in Cancer Research.

PY - 2003/12

Y1 - 2003/12

N2 - Infant acute lymphoblastic leukemia (ALL) is frequently characterized by the t(4;11)(q21;q23) cytogenetic abnormality encoding the MLL/AF4 oncogene, increased HOX gene expression and a pro-B/monocytoid phenotype. We have previously established a novel MLL/AF4-positive cell line, B-lineage 3 (BLIN-3), which retains several features of normal B-lineage development (functional Ig gene rearrangement and apoptotic sensitivity to stromal cell withdrawal) not generally observed in Infant ALL. We now use microarray analysis to identify patterns of gene expression in BLIN-3 that may modulate MLL/AF4 oncogenesis and contribute to the retention of normal B-lineage developmental characteristics. Comparison of 6815 expressed genes in BLIN-3 with published microarray data on leukemic blasts from t(4;11) patients indicated that BLIN-3 was unique in lacking the expression of certain HOX-A cluster genes. These results were validated by RT-PCR showing no expression of HOX A7 or HOX A9 in BLIN-3. A HOX C8 promoter reporter was active in BLIN-3, indicating that lack of HOX gene expression in BLIN-3 was not due to a nonfunctional MLL/AF4. Our results suggest that B-lineage development can proceed in t(4;11) leukemic blasts in the absence of HOX-A gene expression.

AB - Infant acute lymphoblastic leukemia (ALL) is frequently characterized by the t(4;11)(q21;q23) cytogenetic abnormality encoding the MLL/AF4 oncogene, increased HOX gene expression and a pro-B/monocytoid phenotype. We have previously established a novel MLL/AF4-positive cell line, B-lineage 3 (BLIN-3), which retains several features of normal B-lineage development (functional Ig gene rearrangement and apoptotic sensitivity to stromal cell withdrawal) not generally observed in Infant ALL. We now use microarray analysis to identify patterns of gene expression in BLIN-3 that may modulate MLL/AF4 oncogenesis and contribute to the retention of normal B-lineage developmental characteristics. Comparison of 6815 expressed genes in BLIN-3 with published microarray data on leukemic blasts from t(4;11) patients indicated that BLIN-3 was unique in lacking the expression of certain HOX-A cluster genes. These results were validated by RT-PCR showing no expression of HOX A7 or HOX A9 in BLIN-3. A HOX C8 promoter reporter was active in BLIN-3, indicating that lack of HOX gene expression in BLIN-3 was not due to a nonfunctional MLL/AF4. Our results suggest that B-lineage development can proceed in t(4;11) leukemic blasts in the absence of HOX-A gene expression.

KW - 11)

KW - AF4

KW - B-cell development

KW - HOX

KW - Leukemia

KW - MLL

KW - Microarray

KW - T(4

UR - http://www.scopus.com/inward/record.url?scp=0347917090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347917090&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2403178

DO - 10.1038/sj.leu.2403178

M3 - Article

C2 - 14562113

AN - SCOPUS:0347917090

SN - 0887-6924

VL - 17

SP - 2454

EP - 2459

JO - Leukemia

JF - Leukemia

IS - 12

ER -

B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this